-
Tofts, LJ, Armstrong, JA, Broley, S, Carroll, T, Ireland, PJ, Koo, M, Langdon, K, McGregor, L, McKenzie, F, Mehta, D, et al.
Australian guidelines for the management of children with achondroplasia..
J Paediatr Child Health
59(2)
:
229 -241
2023
view publication
-
Hoover-Fong, J, Irving, M, Bacino, C, Charrow, J, Cormier-Daire, V, Polgreen, L, Harmatz, P, Huntsman-Labed, A, Fisheleva, E, Sabir, I, et al.
P194: Persistence of growth promoting effects in children with achondroplasia over seven years: Update from phase II extension study with vosoritide*.
Genetics in Medicine Open
1(1)
:
100223
2023
view publication
-
Hoover-Fong, J, Savarirayan, R, Tofts, L, Irving, M, Wilcox, W, Bacino, C, Font, RU, Harmatz, P, Rutsch, F, Bober, M, et al.
P193: Persistent growth-promoting effects of vosoritide in children with achondroplasia for up to 3.5 years: Update from phase 3 extension study*.
Genetics in Medicine Open
1(1)
:
100222
2023
view publication
-
Bacino, C, Savarirayan, R, Wilcox, W, Harmatz, P, Phillips, J, Polgreen, L, Tofts, L, Ozono, K, Arundel, P, Irving, M, et al.
O22: A randomized controlled trial of vosoritide in infants and toddlers with achondroplasia*.
Genetics in Medicine Open
1(1)
:
100118
2023
view publication
-
Savarirayan, R, Irving, M, Harmatz, P, Delgado, B, Wilcox, WR, Philips, J, Owen, N, Bacino, CA, Tofts, L, Charrow, J, et al.
Growth parameters in children with achondroplasia: A 7-year, prospective, multinational, observational study..
Genet Med
24(12)
:
2444 -2452
2022
view publication